An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Patients With Generalized Anxiety Disorder
Clinical trial NCT00332891 · COMPLETED
Trial details
- NCT number
- NCT00332891
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-01
- Primary completion
- 2007-04-01
- Enrollment
- 508
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.